Avicanna’s subsidiary obtains GPP certification and authorization by INVIMA for the compounding and sale of pharmaceutical cannabinoid products with medical prescriptions in Colombia

Canada NewsWire TORONTO, Sept. 14, 2020 /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO

Read more

Featured Interview: CEO Dr. Jennifer Bath of Immunoprecise Antibodies Ltd. (OTCQB: IPATF)

CEO Dr. Jennifer Bath of Immunoprecise Antibodies Ltd., discusses antibody discovery platforms, recent revenue growth, and providing solutions for the global research industry.

Read more

Featured Interview: CEO Robert Davidson of CURE Pharmaceutical Holding Corp. (OTCQB: CURR)

CEO Robert Davidson of CURE Pharmaceutical Holding Corp., talks about licenses granted to them, working towards precise dosing, and navigating the ever changing regulatory guidelines.

Read more

Easton Signs Agreement to Acquire Commercial Bakery with Projected Revenues Over $20,000,000 per Year and Positioned to Enter the Cannabis Edibles Market

TORONTO, ON, March 05, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Easton Pharmaceuticals Inc. (OTC: EAPH) announces that it has signed

Read more